Since 2001, PATH has brought our global health expertise and innovative approaches to the fight against tuberculosis. We work hand in hand with global partners with a special focus on high-burden countries.

This issue of Directions in Global Health features work by OneWorld Health, PATH’s drug development program, to lead development of innovative methods to enhance the supply of artemisinin, a key ingredient in malaria treatments. It includes a commentary by Dr. Ponni Subbiah, who directs PATH’s drug development efforts. Other articles cover work to improve cervical cancer screening, protect infants from respiratory syncytial virus, increase access to family planning, and strengthen and expand use of human milk banking.

This report dissects research results assessing access to and use of public tuberculosis (TB) diagnostic services in nine districts of Vietnam. The report identifies barriers to accessing public-sector TB diagnostic services at the individual, provider, and health system levels.

The fourth annual policy report from the Global Health Technologies Coalition outlines actions the United States can take to help reduce deaths, extend lives, and secure healthier futures by supporting research for new health tools.

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It examines the second component of a successful cervical cancer prevention program—screening and treatment of adult women for precancerous lesions—based on human papillomavirus (HPV) vaccination demonstration projects that PATH conducted from 2006 to 2011 in India, Peru, Uganda, and Vietnam.

In low-resource settings, diabetes and tuberculosis are common among the same populations, and they amplify each other. PATH's principles and experiences guide our work in fighting these intersecting epidemics through innovation and collaboration.

The global diabetes epidemic impacts pregnant women and their babies. This poster describes a rapid, low-cost, non-fasting screening assay proposed by PATH to be used at antenatal care visits. The test would enable interventions to prevent or delay diabetes in the mother and child.

This edition of PATH Today features our work to protect children from diarrheal disease, the use of mobile devices to diagnose tuberculosis and improve maternal health, and a profile of PATH donor Ann Hayes. The issue also provides information about our yearly reports to donors, workplace and planned giving, and the results of the meningitis vaccine campaign launch in sub-Saharan Africa.

This fact sheet from the Global Health Technologies Coalition provides specific recommendations to US policymakers about the role and engagement of the US government in a future advance market commitment.

This report provides an overview of Nicaragua's health system and diagnostic needs. It is supported by individual case studies on Chagas disease, dengue, and malaria in Nicaragua. These studies focus on several factors influencing the health care system in Nicaragua, including recent trends, regional and national control strategies, financing and partnerships, and the unmet clinical needs associated with each illness.